BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31498712)

  • 21. Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer.
    Takei H; Suemasu K; Kurosumi M; Horii Y; Yoshida T; Ninomiya J; Yoshida M; Hagiwara Y; Kamimura M; Hayashi Y; Inoue K; Tabei T
    Breast Cancer; 2007; 14(1):16-24. PubMed ID: 17244989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
    Giuliano AE; Ballman K; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Morrow M; Hunt KK
    Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practice Patterns of Radiation Field Design for Sentinel Lymph Node-Positive Early-Stage Breast Cancer.
    Azghadi S; Daly M; Mayadev J
    Clin Breast Cancer; 2016 Oct; 16(5):410-417.e3. PubMed ID: 27266803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The intraoperative assessment of sentinel nodes - Standards and controversies.
    van der Noordaa MEM; Vrancken Peeters MTFD; Rutgers EJT
    Breast; 2017 Aug; 34 Suppl 1():S64-S69. PubMed ID: 28673534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort
    Houvenaeghel G; de Nonneville A; Cohen M; Chopin N; Coutant C; Reyal F; Mazouni C; Gimbergues P; Azuar AS; Chauvet MP; Classe JM; Daraï E; Martinez A; Rouzier R; de Lara CT; Lambaudie E; Barrou J; Goncalves A
    ESMO Open; 2021 Jun; 6(3):100151. PubMed ID: 33984674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors Predictive of Sentinel Lymph Node Involvement in Primary Breast Cancer.
    Malter W; Hellmich M; Badian M; Kirn V; Mallmann P; Krämer S
    Anticancer Res; 2018 Jun; 38(6):3657-3662. PubMed ID: 29848724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the presence of sentinel lymph node macrometastases in breast cancer patients require axillary lymph node dissection?-Single-center analysis.
    Nowikiewicz T; Zegarski W; Pagacz K; Nowacki M; Morawiec-Sztandera A; Głowacka-Mrotek I; Sowa M; Biedka M; Kołacińska A
    Breast J; 2018 Sep; 24(5):724-729. PubMed ID: 29476570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel lymph node biopsy after previous axillary surgery: A review.
    Kothari MS; Rusby JE; Agusti AA; MacNeill FA
    Eur J Surg Oncol; 2012 Jan; 38(1):8-15. PubMed ID: 22032909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.
    Bonneau C; Hequet D; Estevez JP; Pouget N; Rouzier R
    Eur J Surg Oncol; 2015 Aug; 41(8):998-1004. PubMed ID: 25986854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical implications of axillary sentinel lymph node 'micrometastases' in breast cancer.
    Krauth JS; Charitansky H; Isaac S; Bobin JY
    Eur J Surg Oncol; 2006 May; 32(4):400-4. PubMed ID: 16504456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society.
    Imoto S; Yamauchi C; Komoike Y; Tsugawa K; Yotsumoto D; Wada N; Ueno T; Oba MS; Shien T; Sugae S; Tsuda H; Yoneyama K
    Breast Cancer; 2017 May; 24(3):427-432. PubMed ID: 27553957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Will we need lymph node dissection at all in the future?
    Bourez RL; Rutgers EJ; Van De Velde CJ
    Clin Breast Cancer; 2002 Dec; 3(5):315-22; discussion 323-5. PubMed ID: 12533260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is regional nodes radiotherapy an alternative to surgery?
    Offersen BV; Nielsen HM; Overgaard M; Overgaard J
    Breast; 2013 Aug; 22 Suppl 2():S118-28. PubMed ID: 24074772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adjuvant treatments in breast cancer: interest of completion of axillary dissection in case of micrometastases or isolated tumor cells in sentinel lymph node].
    Schmitt C; Bouteille C; Faure C; Mignotte H; Tredan O; Bachelot T; Guastalla JP; Arnaud A; Treilleux I; Carrabin N
    Bull Cancer; 2012 Apr; 99(4):463-9. PubMed ID: 22266799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000.
    Solá M; Alberro JA; Fraile M; Santesteban P; Ramos M; Fabregas R; Moral A; Ballester B; Vidal S
    Ann Surg Oncol; 2013 Jan; 20(1):120-7. PubMed ID: 22956062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel Lymph Node Biopsy in Breast Cancer: Indications, Contraindications, and Controversies.
    Manca G; Rubello D; Tardelli E; Giammarile F; Mazzarri S; Boni G; Chondrogiannis S; Marzola MC; Chiacchio S; Ghilli M; Roncella M; Volterrani D; Colletti PM
    Clin Nucl Med; 2016 Feb; 41(2):126-33. PubMed ID: 26447368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there a requirement for axillary lymph node dissection following identification of micro-metastasis or isolated tumour cells at sentinel node biopsy for breast cancer?
    Joyce DP; Solon JG; Prichard RS; Power C; Hill AD
    Surgeon; 2012 Dec; 10(6):326-9. PubMed ID: 22386798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.